1 Zhang Y,Huang H,Jin L,et al.Anticarcinogenic effects of isothiocyanates on hepatocellular carcinoma[J].Int J Mol Sci,2022,23(22):13834-13847. 2 Friemel J,Frick L,Unger K,et al.Characterization of HCC mouse models:towards an etiology-oriented subtyping approach[J].Molecular Cancer Research,2019,17(7):1493-1502. 3 Kurma K,Manches O,Chuffart F,et al.DEN-Induced rat model reproduces key features of human hepatocellular carcinoma[J].Cancers,2021,13(19):4981-4992. 4 Gu CY,Lee TKW.Preclinical mouse models of hepatocellular carcinoma:an overview and update[J].Exp Cell Res,2022,412(2):113042-113054. 5 Yamada S,Takashina Y,Watanabe M,et al.Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice[J].Oncotarget,2018,9(11):9925-9939. 6 Zhang HE,Henderson JM,Gorrell MD.Animal models for hepatocellular carcinoma[J].Biochim Biophys Acta Mol Basis Dis,2019,1865(5):993-1002. 7 王靳琎,李雪莹,易进科,等.小鼠原发性肝癌模型的建立[J].中国应用生理学杂志,2022,38(6):820-823. 8 Connor F,Rayner TF,Aitken SJ,et al.Mutational landscape of a chemically-induced mouse model of liver cancer[J].J Hepatol,2018,69(4):840-850. 9 Dow M,Pyke RM,Tsui BY,et al.Integrative genomic analysis of mouse and human hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,2018,115(42):9879-9888. 10 Fu H,Tang B,Lang J,et al.High-fat diet promotes macrophage-mediated hepatic inflammation and aggravates diethylnitrosamine-induced hepatocarcinogenesis in mice[J].Front Nutr,2020,7(1):585306-585317. 11 黄梓涵,孔亮,严艾文,等.楮实子水提物对二乙基亚硝胺诱发小鼠肝细胞癌的抑制作用及PTEN/PI3K/Akt信号通路的影响[J].中国实验方剂学杂志,2023,29(22):29-36. 12 屈琳琳,刘彦楠,范代娣.人参皂苷Rg5通过诱导凋亡抑制原发性肝癌小鼠肿瘤生长[J].生物加工过程,2023,21(5):582-588. 13 Memon A,Pyao Y,Jung Y,et al.A modified protocol of diethylnitrosamine administration in mice to model hepatocellular carcinoma[J].Int J Mol Sci,2020,21(15):1-14. 14 González-Romero F,Mestre D,Aurrekoetxea I,et al.E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment[J].Cancer Res,2021,81(11):2874-2887. 15 Li E,Lin L,Chen CW,et al.Mouse models for immunotherapy in hepatocellular carcinoma[J].Cancers(Basel),2019,11(11):1-16. 16 冯朵,王靖,蒋勇军,等.肉苁蓉总苷对HepG2肝癌荷瘤小鼠的影响[J].食品科学,2024,45(6):120-129. 17 Zhou H,Du Y,Wei X,et al.DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling[J].Theranostics,2022,12(14):6069-6087. 18 Okada S,Vaeteewoottacharn K,Kariya R.Application of highly immunocompromised mice for the establishment of patient-derived xenograft(PDX)models[J].Cells,2019,8(8):889-907. 19 He L,Tian DA,Li PY,et al.Mouse models of liver cancer:Progress and recommendations[J].Oncotarget,2015,6(27):23306-23322. 20 Akimoto J,Nakayama M,Takagi S,et al.Improved in vivo subcutaneous tumor generation by cancer cell sheet transplantation[J].Anticancer Res,2018,38(2):671-676. 21 Zhang Y,Zhang GL,Sun X,et al.Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation[J].Oncol Lett,2018,15(5):6233-6240. 22 Ma WK,Voss DM,Scharner J,et al.ASO-Based PKM splice-switching therapy inhibits hepatocellular carcinoma growth[J].Cancer Res,2022,82(5):900-915. 23 Okada S,Vaeteewoottacharn K,Kariya R.Application of Highly immunocompromised mice for the establishment of patient-derived xenograft(PDX)models[J].Cells,2019,8(8):1-18. 24 Xu W,Zhao ZY,An QM,et al.Comprehensive comparison of patient-derived xenograft models in hepatocellular carcinoma and metastatic Liver cancer[J].International journal of medical sciences,2020,17(18):3073-3082. 25 Ito R,Takahashi T,Ito M.Humanized mouse models:Application to human diseases[J].J Cell Physiol,2018,233(5):3723-3728. 26 Hajighasemlou S,Pakzad S,Ai J,et al.Characterization and validation of hepatocellular xcrcinoma(HCC)xenograft tumor as a suitable liver cancer model for preclinical mesenchymal stem cell studies[J].Asian Pac J Cancer Prev,2018,19(6):1627-1631. 27 杨梦莹,段永强,贾育新,等.基于NLRP3/Caspase-1/GSDMD炎性焦亡途径探讨参芪抑瘤方联合顺铂对H22肝癌荷瘤小鼠的作用机制[J].中国实验方剂学杂志,2023,29(21):114-122. 28 李月,李玉瑶,冯海,等.淫羊藿素通过阻断Notch信号通路抑制肝癌增殖[J].中华中医药学刊,2023,41(11):134-137. 29 程艳婷,朱涛,马艳竹,等.麦粒灸通过调控凋亡因子半胱氨酸家族增强环磷酰胺对Hepa1-6肝癌荷瘤小鼠的抗肿瘤作用[J].针刺研究,2023,48(9):914-922. 30 Yuan F,Gao Q,Tang H,et al.Ophiopogonin B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways[J].Mol Med Rep,2022,25(4):1-10. 31 Yu Z,Guo J,Hu M,et al.Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma[J].ACS Nano,2020,14(4):4816-4828. 32 Dai W,Xu L,Yu X,et al.OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism[J].J Hepatol,2020,72(5):909-923. 33 Brown ZJ,Heinrich B,Greten TF.Mouse models of hepatocellular carcinoma:an overview and highlights for immunotherapy research[J].Nat Rev Gastroenterol Hepatol,2018,15(9):536-554. 34 Cigliano A,Pilo MG,Li L,et al.Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis[J].Oncotarget,2017,8(53):90638-90650. 35 Chiu DK,Yuen VW,Cheu JW,et al.Hepatocellular carcinoma cells Up-regulate PVRL1,stabilizing PVR and inhibiting the cytotoxic T-cell response via TIGIT to mediate tumor resistance to PD1 inhibitors in mice[J].Gastroenterology,2020,159(2):609-623. 36 Suda T,Yokoo T,Kanefuji T,et al.Hydrodynamic delivery:characteristics,qpplications,and technological advances[J].Pharmaceutics,2023,15(4):1-22. 37 Kamimura K,Yokoo T,Abe H,et al.Effect of diphtheria toxin-based gene therapy for hepatocellular carcinoma[J].Cancers(Basel),2020,12(2):1-16. 38 Mo Y,Wu Y,Li X,et al.Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation[J].Eur J Pharmacol,2020,867(1):172788-172804. |